Adverse events · Older adults with root caries in permanent (mature) teeth (mean age 75 years)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · Patients with taste disturbances (dysgeusia/hypogeusia; idiopathic, zinc-deficient, or secondary to chronic renal failure)
It is very uncertain whether zinc supplements (zinc sulphate, zinc gluconate, zinc picolinate,… changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Patients with idiopathic dysgeusia and hypogeusia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · Children up to 13 years of age, undergoing cleft lip repair surgery
1 finding from 1 review
Adverse events · Children and adolescents having orthodontic separator placement (without local anaesthetic)
1 finding from 1 review
Adverse events · People of any age and either sex, in any setting, with BRONJ; bisphosphonate exposure past or current; includes people with cancer and…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
0 studies
No studies found
Adverse events · maintenance of remission in Crohn's disease
It is very uncertain whether anti‐TB therapy changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Patients with active Crohn's disease
Azathioprine showed no clear difference in adverse events compared with infliximab (moderate certainty).
1 finding from 1 review
Adverse events · Patients with active Crohn's disease
Azathioprine + infliximab showed no clear difference in adverse events compared with infliximab (moderate certainty).
1 finding from 1 review
Adverse events · Patients with active Crohn's disease
Azathioprine or 6‐mercaptopurine may leads to lower adverse events compared with methotrexate (low certainty).
1 finding from 1 review
Adverse events · People with toxoplasma retinochoroiditis
Antibiotic showed no clear difference in adverse events compared with no treatment (low certainty).
1 finding from 1 review
Adverse events · patients with maintenance of medically‐induced remission in Crohn's disease
5‐ASA showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · Ventilator‐associated pneumonia
Monotherapy showed no clear difference in adverse events compared with combination therapy (moderate certainty).
1 finding from 1 review
Adverse events · Ventilator‐associated pneumonia
Carbapenems showed no clear difference in adverse events compared with non‐carbapenems (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · acute treatment of migraine in children
The intervention showed no clear difference in adverse events; GRADE not reported.
1 finding from 1 review
Intervention not reported
Adverse events · acute treatment of migraine in children
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · acute treatment of migraine in adolescents
The intervention probably leads to higher adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · acute treatment of migraine in adolescents
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · people with stroke
The intervention led to lower adverse events; GRADE not reported.
1 finding from 1 review
OR 0.65
2004 participants
GRADE not reported